Market Tracker

05/22 10:01pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.32
Delayed Data
As of May 22
 +0.01 / +0.76%
Today’s Change
0.97
Today|||52-Week Range
2.02
-30.16%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.31
Today’s open1.30
Day’s range1.28 - 1.33
Volume445,392
Average volume (3 months)501,175
Market cap$199.0M
Dividend yield--
Data as of 4:02pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+31.43%
Earnings growth (this year)+30.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+454.99%
P/E ratioNM
Price/Sales44.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc+0.01+0.22%
HSKAHeska Corp+0.01+0.03%
RPRXRepros Therapeutics ...0.000.00%
PTBIPlasmaTech Biopharma...-0.09-1.02%
Data as of 3:59pm ET, 05/22/2015

Financials

Last reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$6.3M
Annual profit (last year)-$35.7M
Net profit margin-569.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts